0000950170-24-046419.txt : 20240422
0000950170-24-046419.hdr.sgml : 20240422
20240422160511
ACCESSION NUMBER: 0000950170-24-046419
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240205
FILED AS OF DATE: 20240422
DATE AS OF CHANGE: 20240422
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jeynes-Ellis Allison M
CENTRAL INDEX KEY: 0001758521
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 24861177
MAIL ADDRESS:
STREET 1: FLAT 52
STREET 2: WILLIAM HUNT MANSIONS
CITY: LONDON
STATE: X0
ZIP: SW13 8HT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
ownership.xml
4
X0508
4
2024-02-05
0001098972
AGENUS INC
AGEN
0001758521
Jeynes-Ellis Allison M
C/O AGENUS INC.
3 FORBES ROAD
LEXINGTON
MA
02421
true
false
false
false
false
Stock Option
12.6
2024-02-05
4
A
false
5000
0.00
A
2034-02-05
Common Stock
5000
5000
D
The Stock Options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan on February 5, 2024 and will vest on February 5, 2025. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 100,000 Stock Options with an exercise price of $0.63.
/s/Christine Klaskin, as Attorney-in-Fact for Allison Jeynes-Ellis
2024-04-22